Diagnostics
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Selected Work

RNA-based Oncology Biomarker Market Landscape
Voice-of-Customer Research
Competitive Analysis
Biomarker and Diagnostics Strategy
Product Specification Mapping

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing
Customer Segmentation
Voice-of-Customer Research
Market Landscaping and Sizing

NIPT Market Landscape and Strategy
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Go-to-Market Strategy






.png)
.png)



